Identification & management of defects in platelet hemostasis in massively transfused patients.
D000818:Animals; D001241:Aspirin / Q000009:adverse effects; D001760:Bleeding Time; D001793:Blood Preservation; D001803:Blood Transfusion / Q000401:mortality; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D002470:Cell Survival; D004285:Dogs; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006487:Hemostasis; D006801:Humans; D008297:Male; D010107:Oxygenators, Membrane / Q000009:adverse effects; D010974:Platelet Aggregation; D010976:Platelet Count; D017713:Platelet Transfusion; D011183:Postoperative Complications / Q000097:blood; D011817:Rabbits; D012769:Shock / Q000401:mortality / Q000628:therapy; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D065227:Transfusion Reaction; D014947:Wounds and Injuries / Q000097:blood / Q000401:mortality / Q000628:therapy*
D001241:Aspirin